Literature DB >> 16702365

DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.

J Shawn Jones1, Christopher I Amos, Mala Pande, Xiangjun Gu, Jinyun Chen, Imelda M Campos, Qingyi Wei, Miguel Rodriguez-Bigas, Patrick M Lynch, Marsha L Frazier.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant syndrome of familial malignancies resulting from germ-line mutations in DNA mismatch repair genes. Colorectal and endometrial cancers are most frequently observed. A polymorphic C-to-T change in the promoter region of the DNMT3b gene, -149 bp from the transcription start site, is reported to greatly increase promoter activity and is associated with increased risk for lung cancer and decreased postsurgical survival in patients with small cell carcinoma of the head and neck. We studied the influence of this DNMT3b polymorphism on HNPCC age of onset. We determined the DNMT3b genotype of 146 mismatch repair mutation carriers from 72 families. Of these, 74 participants had colorectal cancer. The participants were genotyped by single-strand conformational polymorphism analysis and DNA sequencing. We tested the association between age of onset and DNMT3b genotypes by comparing Kaplan-Meier survival curves, evaluating the homogeneity of the curves using the log-rank test, Wilcoxon's test, and Fleming-Harrington test and estimating the strength and direction of the association using the Cox proportional hazards regression model adjusting for potential demographic and genetic confounding factors. HNPCC patients carrying one or two copies of the DNMT3b variant T allele developed their colorectal cancer significantly earlier than HNPCC patients who were homozygous for the wild-type DNMT3b allele. Combining knowledge of an individual's DNMT3b genotype with information on other genetic and environmental risk factors may improve risk estimates and help to identify individuals who are genetically susceptible to developing HNPCC at an earlier age.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702365     DOI: 10.1158/1055-9965.EPI-05-0644

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

1.  Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.

Authors:  Qian Bao; Bangshun He; Yuqin Pan; Zhipeng Tang; Ying Zhang; Lili Qu; Yongfei Xu; Chan Zhu; Fuliang Tian; Shukui Wang
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

2.  DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies.

Authors:  Shimiao Zhu; Hui Zhang; Yang Tang; Peicai Liu; Jianmin Wang
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

3.  Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis.

Authors:  Qingkai Meng; Jingru Zhang; Bo Lian; Chun Song
Journal:  Tumour Biol       Date:  2013-11-01

4.  Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study.

Authors:  Zhensheng Liu; Luo Wang; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Cancer Lett       Date:  2008-05-01       Impact factor: 8.679

5.  DNMT3B promoter polymorphism and risk of gastric cancer.

Authors:  Jiabo Hu; Hong Fan; Dongsheng Liu; Shuhong Zhang; Feng Zhang; Huaxi Xu
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

Review 6.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

7.  The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer.

Authors:  Daniel Hernández-Sotelo; Rubén García-Aguilar; Yaneth Castro-Coronel; Jonathan J Magaña; Marco Antonio Leyva-Vazquez; Luz del Carmen Alarcón-Romero; Esther López-Bayghen; Berenice Illades-Aguiar
Journal:  Mol Biol Rep       Date:  2013-05-16       Impact factor: 2.316

8.  DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study.

Authors:  Ying Wu; Ju-Sheng Lin
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

Review 9.  Cancer genomics identifies disrupted epigenetic genes.

Authors:  Laia Simó-Riudalbas; Manel Esteller
Journal:  Hum Genet       Date:  2013-10-09       Impact factor: 4.132

10.  DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.

Authors:  Katsuhiko Nosho; Kaori Shima; Natsumi Irahara; Shoko Kure; Yoshifumi Baba; Gregory J Kirkner; Li Chen; Sumita Gokhale; Aditi Hazra; Donna Spiegelman; Edward L Giovannucci; Rudolf Jaenisch; Charles S Fuchs; Shuji Ogino
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.